Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.
about
Exosome-associated AAV vector as a robust and convenient neuroscience toolGene therapy for the nervous system: challenges and new strategies.In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene TherapyAdeno-associated viral vectors for the treatment of hemophilia.Recombinant adeno-associated virus vectors in the treatment of rare diseases.Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injectionAchieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.Viral vectors for therapy of neurologic diseases.Extracellular vesicles and intercellular communication within the nervous system.Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells.Unraveling the complex story of immune responses to AAV vectors trial after trial.Extracellular vesicles: nature's nanoparticles for improving gene transfer with adeno-associated virus vectors.Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV.Extracellular vesicles as enhancers of virus vector-mediated gene delivery.Oligonucleotide conjugated multi-functional adeno-associated viruses.Enhanced Production of Exosome-Associated AAV by Overexpression of the Tetraspanin CD9.CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.Biodistribution, Uptake and Effects Caused by Cancer-Derived Extracellular Vesicles.Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.
P2860
Q27323458-CBAB8097-D4A1-4CE4-8A00-16FFE160A76EQ35340196-290EFBA5-5DA8-4A8A-8D5E-FBCBA96420E8Q35999976-43E0682E-1216-48A1-B028-9AA5435848E6Q36713767-E8950527-33E6-45B4-BCA0-B8A281695BF9Q37279525-61AE46A2-F519-488A-B87A-1A90AEFEF8E3Q37731427-226D8F8D-E104-4B4A-B221-7D8B50532812Q38743388-921D6BCF-2866-432A-A2DA-BB0F3833047EQ38746238-EC677DD7-DF7F-4EDB-9D42-0054458F6D2BQ38795618-56E92905-F261-4A86-9883-4EFF0D9F65CFQ39309884-4E164DAD-576F-448B-A7AB-9D102A60441BQ40073271-7F2898C6-5C5F-4C04-9CE0-116806CE5E00Q40086322-865B17B7-5B19-4255-A054-56469AEA9762Q40383155-966AF8F5-679C-4607-BE99-B9F354607C36Q41836278-BD949570-5E80-40FD-8569-025E96383DF0Q50333514-17079EF1-43F3-42CB-945B-3AC5566BB142Q54225479-BAF064C6-F1D1-4154-9B3E-AF242F0C1966Q54957718-5D1C24DB-DD5A-4848-80BD-0873BC9B961DQ55431439-98A72FFE-2E1A-497F-A46E-876E91412115Q55461485-649722B7-331E-4C56-A38E-06F87EE82C94
P2860
Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Naturally enveloped AAV vector ...... robust gene delivery in vivo.
@ast
Naturally enveloped AAV vector ...... robust gene delivery in vivo.
@en
type
label
Naturally enveloped AAV vector ...... robust gene delivery in vivo.
@ast
Naturally enveloped AAV vector ...... robust gene delivery in vivo.
@en
prefLabel
Naturally enveloped AAV vector ...... robust gene delivery in vivo.
@ast
Naturally enveloped AAV vector ...... robust gene delivery in vivo.
@en
P2093
P2860
P1433
P1476
Naturally enveloped AAV vector ...... robust gene delivery in vivo.
@en
P2093
Bence György
Casey A Maguire
Zachary Fitzpatrick
P2860
P304
P356
10.1016/J.BIOMATERIALS.2014.05.032
P577
2014-06-07T00:00:00Z